These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15193436

  • 1. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
    van Dartel M, Redeker S, Bras J, Kool M, Hulsebos TJ.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):8-14. PubMed ID: 15193436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T, Wunder JS, Gokgoz N, Gill M, Eskandarian S, Parkes RK, Bull SB, Bell RS, Andrulis IL.
    Cancer; 2007 May 01; 109(9):1870-6. PubMed ID: 17366602
    [Abstract] [Full Text] [Related]

  • 4. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.
    van Dartel M, Cornelissen PW, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PC, Westerveld A, Gomes I, Bras J, Hulsebos TJ.
    Cancer Genet Cytogenet; 2002 Dec 01; 139(2):91-6. PubMed ID: 12550767
    [Abstract] [Full Text] [Related]

  • 5. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
    Both J, Wu T, Bras J, Schaap GR, Baas F, Hulsebos TJ.
    PLoS One; 2012 Dec 01; 7(1):e30907. PubMed ID: 22292074
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SAS is amplified predominantly in surface osteosarcoma.
    Noble-Topham SE, Burrow SR, Eppert K, Kandel RA, Meltzer PS, Bell RS, Andrulis IL.
    J Orthop Res; 1996 Sep 01; 14(5):700-5. PubMed ID: 8893761
    [Abstract] [Full Text] [Related]

  • 8. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
    Fabris S, Todoerti K, Mosca L, Agnelli L, Intini D, Lionetti M, Guerneri S, Lambertenghi-Deliliers G, Bertoni F, Neri A.
    Genes Chromosomes Cancer; 2007 Dec 01; 46(12):1109-18. PubMed ID: 17823926
    [Abstract] [Full Text] [Related]

  • 9. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M.
    Genes Chromosomes Cancer; 2003 Nov 01; 38(3):215-25. PubMed ID: 14506695
    [Abstract] [Full Text] [Related]

  • 10. Characterization of PMP22 expression in osteosarcoma.
    van Dartel M, Hulsebos TJ.
    Cancer Genet Cytogenet; 2004 Jul 15; 152(2):113-8. PubMed ID: 15262428
    [Abstract] [Full Text] [Related]

  • 11. Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma.
    van Dartel M, Leenstra S, Troost D, Hulsebos TJ.
    Cancer Genet Cytogenet; 2003 Jan 15; 140(2):162-6. PubMed ID: 12645656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.
    Both J, Wu T, Ten Asbroek AL, Baas F, Hulsebos TJ.
    Cytogenet Genome Res; 2016 Jan 15; 150(1):52-59. PubMed ID: 27846620
    [Abstract] [Full Text] [Related]

  • 14. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA.
    Genes Chromosomes Cancer; 2009 Aug 15; 48(8):679-93. PubMed ID: 19441093
    [Abstract] [Full Text] [Related]

  • 15. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.
    Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, Novokmet A, Malkin D.
    Cancer Res; 2010 Jan 01; 70(1):160-71. PubMed ID: 20048075
    [Abstract] [Full Text] [Related]

  • 16. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M, Park CK, Lewis R, Jhanwar SC, Healey JH, Huvos AG.
    Diagn Mol Pathol; 1993 Sep 01; 2(3):163-7. PubMed ID: 8287230
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
    Shang J, Bi ZG, Ji HF, Wang WB.
    Chin Med J (Engl); 2009 Jul 05; 122(13):1521-4. PubMed ID: 19719941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
    Entz-Werlé N, Marcellin L, Gaub MP, Guerin E, Schneider A, Berard-Marec P, Kalifa C, Brugiere L, Pacquement H, Schmitt C, Tabone MD, Jeanne-Pasquier C, Terrier P, Dijoud F, Oudet P, Lutz P, Babin-Boilletot A.
    J Clin Oncol; 2005 Apr 01; 23(10):2248-55. PubMed ID: 15800315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.